“It’s the best thing that has ever happened to me” - this is the first approved drug designed to treat the cause of narcolepsy
go.nature.com/3TSRgk3
go.nature.com/3TSRgk3
First-of-its-kind narcolepsy drug opens door to new therapies for the brain
The drug, called Orzeyful, takes aim at the root cause of the sleep disorder rather than at its symptoms.
go.nature.com
August 17, 2026 at 4:05 PM
“It’s the best thing that has ever happened to me” - this is the first approved drug designed to treat the cause of narcolepsy
go.nature.com/3TSRgk3
go.nature.com/3TSRgk3
“It’s the best thing that has ever happened to me” - this is the first approved drug designed to treat the cause of narcolepsy
go.nature.com/4hMj3fL
go.nature.com/4hMj3fL
First-of-its-kind narcolepsy drug opens door to new therapies for the brain
Nature - The drug, called Orzeyful, takes aim at the root cause of the sleep disorder rather than at its symptoms.
go.nature.com
August 22, 2026 at 1:34 PM
“It’s the best thing that has ever happened to me” - this is the first approved drug designed to treat the cause of narcolepsy
go.nature.com/4hMj3fL
go.nature.com/4hMj3fL
#BREAKING: The FDA has approved ORZEYFUL (oveporexton) on August 5, 2026, making it the first #orexin agonist approved for adults living with #narcolepsy type 1 in the United States.
🧠✨
To read more, visit project-sleep.com/orzeyful-fda...
#Breakthrough #Health #Medsky #SleepMedicine #Neurology
🧠✨
To read more, visit project-sleep.com/orzeyful-fda...
#Breakthrough #Health #Medsky #SleepMedicine #Neurology
August 5, 2026 at 11:00 PM
#BREAKING: The FDA has approved ORZEYFUL (oveporexton) on August 5, 2026, making it the first #orexin agonist approved for adults living with #narcolepsy type 1 in the United States.
🧠✨
To read more, visit project-sleep.com/orzeyful-fda...
#Breakthrough #Health #Medsky #SleepMedicine #Neurology
🧠✨
To read more, visit project-sleep.com/orzeyful-fda...
#Breakthrough #Health #Medsky #SleepMedicine #Neurology
First-of-its-kind narcolepsy drug opens door to new therapies for the brain www.nature.com/articles/d41...
First-of-its-kind narcolepsy drug opens door to new therapies for the brain
The drug, called Orzeyful, takes aim at the root cause of the sleep disorder rather than at its symptoms.
www.nature.com
August 20, 2026 at 11:19 AM
First-of-its-kind narcolepsy drug opens door to new therapies for the brain www.nature.com/articles/d41...
Narcolepsy treatment just changed course.
FDA approved Orzeyful for adults with narcolepsy type 1—the first approved drug to target missing orexin signaling and treat the disorder as a whole. U.S. availability awaits DEA scheduling.
www.fda.gov/news-events/...
#Narcolepsy
FDA approved Orzeyful for adults with narcolepsy type 1—the first approved drug to target missing orexin signaling and treat the disorder as a whole. U.S. availability awaits DEA scheduling.
www.fda.gov/news-events/...
#Narcolepsy
August 7, 2026 at 1:31 PM
Narcolepsy treatment just changed course.
FDA approved Orzeyful for adults with narcolepsy type 1—the first approved drug to target missing orexin signaling and treat the disorder as a whole. U.S. availability awaits DEA scheduling.
www.fda.gov/news-events/...
#Narcolepsy
FDA approved Orzeyful for adults with narcolepsy type 1—the first approved drug to target missing orexin signaling and treat the disorder as a whole. U.S. availability awaits DEA scheduling.
www.fda.gov/news-events/...
#Narcolepsy
#Takeda has officially secured approval for #Orzeyful in #China, marking a significant milestone in global #pharmaceutical expansion and patient care. www.ipharmacenter.com/post/takeda-... #news #pharma #healthcare
Takeda Secures Landmark Approval for Orzeyful in China | iPharmaCenter
Takeda China has received approval from the National Medical Products Administration (NMPA) for Orzeyful (oveporexton) as a treatment for Narcolepsy Type 1 (NT1). Also read: Germany Enacts 2026 Health...
www.ipharmacenter.com
July 23, 2026 at 4:17 PM
#Takeda has officially secured approval for #Orzeyful in #China, marking a significant milestone in global #pharmaceutical expansion and patient care. www.ipharmacenter.com/post/takeda-... #news #pharma #healthcare
Ozempic moment for #narcolepsy & #brain?
www.nature.com/articles/d41...
US FDA approves first drug for narcolepsy
— oral pill agonist for orexin-peptide-deficient patients
— 1 in 2000 US residents suffer orexin deficiency
— disrupted sleep/wake cycle, cataplexy, paralysis, hallucination 🧪
www.nature.com/articles/d41...
US FDA approves first drug for narcolepsy
— oral pill agonist for orexin-peptide-deficient patients
— 1 in 2000 US residents suffer orexin deficiency
— disrupted sleep/wake cycle, cataplexy, paralysis, hallucination 🧪
First-of-its-kind narcolepsy drug opens door to new therapies for the brain
The drug, called Orzeyful, takes aim at the root cause of the sleep disorder rather than at its symptoms.
www.nature.com
August 19, 2026 at 11:17 PM
Ozempic moment for #narcolepsy & #brain?
www.nature.com/articles/d41...
US FDA approves first drug for narcolepsy
— oral pill agonist for orexin-peptide-deficient patients
— 1 in 2000 US residents suffer orexin deficiency
— disrupted sleep/wake cycle, cataplexy, paralysis, hallucination 🧪
www.nature.com/articles/d41...
US FDA approves first drug for narcolepsy
— oral pill agonist for orexin-peptide-deficient patients
— 1 in 2000 US residents suffer orexin deficiency
— disrupted sleep/wake cycle, cataplexy, paralysis, hallucination 🧪
Seems to be a big part of the idea - narcolepsy and (presumably) related conditions (restless leg, neurospicy sleep issues, etc.)
www.nature.com/articles/d41...
www.nature.com/articles/d41...
First-of-its-kind narcolepsy drug opens door to new therapies for the brain
The drug, called Orzeyful, takes aim at the root cause of the sleep disorder rather than at its symptoms.
www.nature.com
August 22, 2026 at 12:06 AM
Seems to be a big part of the idea - narcolepsy and (presumably) related conditions (restless leg, neurospicy sleep issues, etc.)
www.nature.com/articles/d41...
www.nature.com/articles/d41...
🧪Earlier this month, the FDA approved the first drug designed to treat the root cause of narcolepsy. Several more of these so-called orexin agonists are on the way, and scientists are finding they can be useful in treating a number of other disorders.
www.nature.com/articles/d41...
www.nature.com/articles/d41...
First-of-its-kind narcolepsy drug opens door to new therapies for the brain
The drug, called Orzeyful, takes aim at the root cause of the sleep disorder rather than at its symptoms.
www.nature.com
August 17, 2026 at 4:11 PM
🧪Earlier this month, the FDA approved the first drug designed to treat the root cause of narcolepsy. Several more of these so-called orexin agonists are on the way, and scientists are finding they can be useful in treating a number of other disorders.
www.nature.com/articles/d41...
www.nature.com/articles/d41...
40 Jahre lang bekamen Narkolepsiepatienten Stimulanzien gegen das Einschlafen. Jetzt gibt es das erste Mittel gegen die echte Ursache.
Orzeyful: Erstes Medikament gegen Narkolepsieursache
Die FDA hat am 5. August 2026 Orzeyful (Oveporexton) von Takeda zugelassen, das erste Medikament, das die biologische Ursache von Narkolepsie Typ 1 direkt bekämpft. Jahrzehntelang blieb die Behandlung auf Symptomkontrolle beschränkt.
denkstrom.org
August 8, 2026 at 1:32 PM
40 Jahre lang bekamen Narkolepsiepatienten Stimulanzien gegen das Einschlafen. Jetzt gibt es das erste Mittel gegen die echte Ursache.
The narcolepsy research that led to Takeda's newly approved sleep drug just won a Lasker Award, after starting with lab banter between two neighboring scientists.
From lab banter to a Lasker Award: The science behind narcolepsy
Masashi Yanagisawa and Emmanuel Mignot win the 2026 Lasker Award for orexin research behind Takeda's newly approved narcolepsy drug Orzeyful.
endpoints.news
September 9, 2026 at 7:39 PM
The narcolepsy research that led to Takeda's newly approved sleep drug just won a Lasker Award, after starting with lab banter between two neighboring scientists.
Narcolepsy's Lost Signal Gets Restored: FDA Approves First Orexin-Targeting Drug
Like, share, follow.
https://1ban.news/orzeyful-oveporexton-narcolepsy-type1-fda/
#1ban #orzeyful #oveporexton #sleep
Like, share, follow.
https://1ban.news/orzeyful-oveporexton-narcolepsy-type1-fda/
#1ban #orzeyful #oveporexton #sleep
August 7, 2026 at 6:11 PM
Narcolepsy's Lost Signal Gets Restored: FDA Approves First Orexin-Targeting Drug
Like, share, follow.
https://1ban.news/orzeyful-oveporexton-narcolepsy-type1-fda/
#1ban #orzeyful #oveporexton #sleep
Like, share, follow.
https://1ban.news/orzeyful-oveporexton-narcolepsy-type1-fda/
#1ban #orzeyful #oveporexton #sleep
Orexin receptor agonist secures landmark narcolepsy approval
nature.com/articles/d41...
As Takeda’s oveporexton (Orzeyful) becomes a first-in-class treatment for narcolepsy type 1, industry eyes broader indications for orexin receptor agonists
nature.com/articles/d41...
As Takeda’s oveporexton (Orzeyful) becomes a first-in-class treatment for narcolepsy type 1, industry eyes broader indications for orexin receptor agonists
August 10, 2026 at 2:13 PM
Orexin receptor agonist secures landmark narcolepsy approval
nature.com/articles/d41...
As Takeda’s oveporexton (Orzeyful) becomes a first-in-class treatment for narcolepsy type 1, industry eyes broader indications for orexin receptor agonists
nature.com/articles/d41...
As Takeda’s oveporexton (Orzeyful) becomes a first-in-class treatment for narcolepsy type 1, industry eyes broader indications for orexin receptor agonists
Narcolepsy isn't one disease — it's five different experiences hiding under one name.
A newly FDA-approved drug, Orzeyful, works differently, it skips the missing neurons entirely and switches the wakefulness receptors.
Subscribe for more
#Narcolepsy #Cataplexy #SleepDisorder #Orexin
A newly FDA-approved drug, Orzeyful, works differently, it skips the missing neurons entirely and switches the wakefulness receptors.
Subscribe for more
#Narcolepsy #Cataplexy #SleepDisorder #Orexin
August 11, 2026 at 1:03 PM
Narcolepsy isn't one disease — it's five different experiences hiding under one name.
A newly FDA-approved drug, Orzeyful, works differently, it skips the missing neurons entirely and switches the wakefulness receptors.
Subscribe for more
#Narcolepsy #Cataplexy #SleepDisorder #Orexin
A newly FDA-approved drug, Orzeyful, works differently, it skips the missing neurons entirely and switches the wakefulness receptors.
Subscribe for more
#Narcolepsy #Cataplexy #SleepDisorder #Orexin
I was (for obvious reasons) too tired yesterday to post this like I meant, but yesterday the FDA announced the approval of the new orexin agonist for narcolepsy and I'm overjoyed www.fda.gov/news-events/...
FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms
The FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.
www.fda.gov
August 6, 2026 at 4:40 PM
I was (for obvious reasons) too tired yesterday to post this like I meant, but yesterday the FDA announced the approval of the new orexin agonist for narcolepsy and I'm overjoyed www.fda.gov/news-events/...
The United States Food and Drug Administration ( FDA ) approved Orzeyful , Takeda's new medication for type 1 narcolepsy, considered a boost for an emerging class of treatments based on orexin receptors.
FDA approves Orzeyful, Takeda's first orexin agonist for narcolepsy - Sinaptica
The United States Food and Drug Administration (FDA) approved Orzeyful, Takeda's new medication for type 1 narcolepsy, considered a boost for an emerging class
sinapti.ca
August 5, 2026 at 10:20 PM
The United States Food and Drug Administration ( FDA ) approved Orzeyful , Takeda's new medication for type 1 narcolepsy, considered a boost for an emerging class of treatments based on orexin receptors.
La Administración de Alimentos y Medicamentos de Estados Unidos ( FDA ) aprobó Orzeyful , el nuevo medicamento de Takeda para narcolepsia tipo 1, considerado un impulso para una clase emergente de tratamientos basados en receptores de orexina.
La FDA aprueba Orzeyful, primer agonista de orexina para narcolepsia de Takeda - Sinaptica
La Administración de Alimentos y Medicamentos de Estados Unidos (FDA) aprobó Orzeyful, el nuevo medicamento de Takeda para narcolepsia tipo 1, considerado un im
sinapti.ca
August 5, 2026 at 10:20 PM
La Administración de Alimentos y Medicamentos de Estados Unidos ( FDA ) aprobó Orzeyful , el nuevo medicamento de Takeda para narcolepsia tipo 1, considerado un impulso para una clase emergente de tratamientos basados en receptores de orexina.
La FDA approva il primo farmaco per il trattamento di tutti i sintomi della narcolessia di tipo 1
Orzeyful* (oveporexton) è il primo a ripristinare direttamente la segnalazione dell'orexina, agendo sulla causa biologica La Food and Drug Administration (FDA) ha approvato le compresse di Orzeyful*…
Orzeyful* (oveporexton) è il primo a ripristinare direttamente la segnalazione dell'orexina, agendo sulla causa biologica La Food and Drug Administration (FDA) ha approvato le compresse di Orzeyful*…
La FDA approva il primo farmaco per il trattamento di tutti i sintomi della narcolessia di tipo 1
Orzeyful* (oveporexton) è il primo a ripristinare direttamente la segnalazione dell'orexina, agendo sulla causa biologica La Food and Drug Administration (FDA) ha approvato le compresse di Orzeyful* (oveporexton) per il trattamento della narcolessia di tipo 1 negli adulti. Orzeyful* è il primo farmaco approvato per la narcolessia di tipo 1 come disturbo completo, in grado di affrontare l'intera gamma di sintomi che definiscono la condizione, ed è il primo ad agire direttamente sulla perdita della segnalazione dell'orexina che causa la malattia.
www.saluteh24.com
August 6, 2026 at 7:20 AM
La FDA approva il primo farmaco per il trattamento di tutti i sintomi della narcolessia di tipo 1
Orzeyful* (oveporexton) è il primo a ripristinare direttamente la segnalazione dell'orexina, agendo sulla causa biologica La Food and Drug Administration (FDA) ha approvato le compresse di Orzeyful*…
Orzeyful* (oveporexton) è il primo a ripristinare direttamente la segnalazione dell'orexina, agendo sulla causa biologica La Food and Drug Administration (FDA) ha approvato le compresse di Orzeyful*…
#Japan hat #GSKs #Hibsago für chronische #HepatitisB und #Takedas #Orzeyful für #Narkolepsie Typ 1 zugelassen www.ipharmacenter.com/post/japan-a...
#Japan #Nachrichten #Medien #Pharma #Gesundheit #Pharmazeutik
#Japan #Nachrichten #Medien #Pharma #Gesundheit #Pharmazeutik
Japan Approves GSK’s Hibsago for Chronic Hepatitis B and Takeda’s Orzeyful for Narcolepsy Type 1
Japan Approves Hibsago for Chronic Hepatitis BJapan has cleared GSK’s Hibsago, also known as bepirovirsen, for adults with chronic hepatitis B who have already received at least six months of nucleos(...
www.ipharmacenter.com
August 24, 2026 at 4:20 PM
#Japan hat #GSKs #Hibsago für chronische #HepatitisB und #Takedas #Orzeyful für #Narkolepsie Typ 1 zugelassen www.ipharmacenter.com/post/japan-a...
#Japan #Nachrichten #Medien #Pharma #Gesundheit #Pharmazeutik
#Japan #Nachrichten #Medien #Pharma #Gesundheit #Pharmazeutik
“For that to lead to a whole new treatment modality is exciting for those of us that live with type 1 #narcolepsy.” Read the Forbes article on the FDA ORZEYFUL approval featuring Julie: https://www.forbes.com/health/conditions/fda-approves-orzeyful-narcolepsy-type-1-lmandp5/ #Medsky #SleepMedicine
August 12, 2026 at 3:16 PM
“For that to lead to a whole new treatment modality is exciting for those of us that live with type 1 #narcolepsy.” Read the Forbes article on the FDA ORZEYFUL approval featuring Julie: https://www.forbes.com/health/conditions/fda-approves-orzeyful-narcolepsy-type-1-lmandp5/ #Medsky #SleepMedicine
#日本 が慢性 #B型肝炎 治療薬として #GSK の #ヒブサゴ （#Hibsago）、#ナルコレプシー 1型治療薬として #武田薬品 の #オーゼイフル （#Orzeyful）を承認
www.ipharmacenter.com/post/japan-a...
#日本 #ニュース #メディア #製薬 #ヘルスケア
www.ipharmacenter.com/post/japan-a...
#日本 #ニュース #メディア #製薬 #ヘルスケア
Japan Approves GSK’s Hibsago for Chronic Hepatitis B and Takeda’s Orzeyful for Narcolepsy Type 1
Japan Approves Hibsago for Chronic Hepatitis BJapan has cleared GSK’s Hibsago, also known as bepirovirsen, for adults with chronic hepatitis B who have already received at least six months of nucleos(...
www.ipharmacenter.com
August 24, 2026 at 4:21 PM
#日本 已批准 #GSK 用于治疗慢性 #乙肝 的 #Hibsago 以及 #武田 用于治疗1型 #发作性睡病 的 #Orzeyful
www.ipharmacenter.com/post/japan-a...
#日本 #新闻 #媒体 #医药 #医疗健康 #生物医药
www.ipharmacenter.com/post/japan-a...
#日本 #新闻 #媒体 #医药 #医疗健康 #生物医药
Japan Approves GSK’s Hibsago for Chronic Hepatitis B and Takeda’s Orzeyful for Narcolepsy Type 1
Japan Approves Hibsago for Chronic Hepatitis BJapan has cleared GSK’s Hibsago, also known as bepirovirsen, for adults with chronic hepatitis B who have already received at least six months of nucleos(...
www.ipharmacenter.com
August 24, 2026 at 4:21 PM
#Narcolepsy type 1 is a lifelong neurological disorder that affects about 1 in 2,000 people in the United States. FDA has approved Orzeyful™ (oveporexton), the first drug addressing the underlying orexin deficit in narcolepsy type 1.
brainhealthinstitute.rutgers.edu/2026/09/07/f...
brainhealthinstitute.rutgers.edu/2026/09/07/f...
FDA Approves First Drug to Treat the Orexin Deficit in Narcolepsy Type 1 - BHI
brainhealthinstitute.rutgers.edu
September 9, 2026 at 12:47 PM
#Narcolepsy type 1 is a lifelong neurological disorder that affects about 1 in 2,000 people in the United States. FDA has approved Orzeyful™ (oveporexton), the first drug addressing the underlying orexin deficit in narcolepsy type 1.
brainhealthinstitute.rutgers.edu/2026/09/07/f...
brainhealthinstitute.rutgers.edu/2026/09/07/f...
www.nature.com/articles/d41...
Boeiende ontwikkelingen in behandeling van narcolepsie ( slaapstoornis)
Boeiende ontwikkelingen in behandeling van narcolepsie ( slaapstoornis)
First-of-its-kind narcolepsy drug opens door to new therapies for the brain
The drug, called Orzeyful, takes aim at the root cause of the sleep disorder rather than at its symptoms.
www.nature.com
August 18, 2026 at 4:20 AM
www.nature.com/articles/d41...
Boeiende ontwikkelingen in behandeling van narcolepsie ( slaapstoornis)
Boeiende ontwikkelingen in behandeling van narcolepsie ( slaapstoornis)